QIAstat-Dx Meningitis/Encephalitis Panel cleared in the U.S. for use in clinical settings to help diagnose central nervous system infections // Fourth FDA clearance marks milestone in 2024 in ...

The new panel marks the fourth FDA clearance of a QIAstat-Dx panel in 2024. All QIAstat-Dx panels are available as cost-efficient, single-use cartridges that slot easily into the QIAstat-Dx ...

This new panel marks the fourth FDA clearance of a QIAstat-Dx panel in 2024, and comes after the recent FDA clearances for other tests: QIAstat-Dx Gastrointestinal Panel 2 QIAstat-Dx Respiratory ...

04, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx Meningitis/Encephalitis ...

There are four stages of passing a kidney stone: The stone forms, leaves the kidney, reaches the bladder and causes pressure, and finally, exits the body. They're common, with about 10% of people in ...